Core Insights - The company reported a revenue of 324 million yuan for the first half of 2025, representing a year-on-year growth of 6.15% [1] - The net profit attributable to shareholders reached 67.6863 million yuan, with a non-recurring net profit of 33.1225 million yuan, showing a significant increase of 31.85% year-on-year [1][2] - The company announced its first mid-year dividend plan, proposing a cash dividend of 40 yuan per 10 shares, totaling 487 million yuan [1][2] Financial Performance - The main driver of performance was high investment in product research and technological innovation, leading to a diverse range of reagent products that meet customer needs [2] - The non-recurring net profit saw a remarkable increase of 31.85%, marking the first positive growth since the pandemic, with a quarter-on-quarter increase of 189% in the second quarter [2] - The company has maintained a steady revenue scale and profitability since its listing four years ago, with accumulated current assets nearing 4 billion yuan and undistributed profits exceeding 1.1 billion yuan [2] Business Operations - The company has established multiple core technology platforms, enabling efficient development of diverse biological reagents tailored to market demands [2][3] - The core business areas, including recombinant proteins, antibodies, and CRO services, demonstrate resilience and long-term growth potential [3] - The company offers over 77,000 types of products, including more than 9,800 recombinant proteins and 15,000 antibodies, supporting various fields of life science research [3] Market Expansion - The company is accelerating its global market layout, having established international market and technical support teams in the US, Germany, Japan, and South Korea [4] - The acquisition of Canadian enzyme protein manufacturer SignalChem Biotech Inc. is part of its strategy to enhance global presence [4] - The company has subsidiaries in Suzhou, Taizhou, and various international locations, with products sold in over 90 countries and regions, serving more than 11,000 customers [4]
义翘神州：首次进行半年报分红 拟每10股派发现金红利40元